← Eichor
Condition: End Stage Renal Disease With Renal Transplant Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: End Stage Renal Disease With Renal Transplant

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Phase 2 · 7 location(s) · Singulera Therapeutics Inc. · NCT06552169Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD
Phase 1/Phase 2 · 2 location(s) · United Therapeutics · NCT06878560Imlifidase Prior to Kidney Transplant in Highly Sensitised Children
Phase 2 · 5 location(s) · Hansa Biopharma AB · NCT05753930A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation
Phase N/A · 25 location(s) · Takeda · NCT06243731Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Phase 3 · 4 location(s) · Dr. F. Köhler Chemie GmbH · NCT03627013A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients
NA · 21 location(s) · W.L.Gore & Associates · NCT04671771Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Phase 1 · 1 location(s) · University of California, Los Angeles · NCT05525507Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
Phase 3 · 34 location(s) · Region Stockholm · NCT05679024Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD
Phase 1/Phase 2 · 1 location(s) · United Therapeutics · NCT07224763CAR-T Cell Therapy for Desensitization in Kidney Transplantation
Phase 1 · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT06056102Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
Phase 3 · 1 location(s) · Nantes University Hospital · NCT05562869Endoscopic Sleeve Gastroplasty With Endomina® for the Treatment of Obesity in Kidney Transplant Candidates
NA · 1 location(s) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · NCT05917795CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants
EARLY_Phase 1 · 1 location(s) · Tongji Hospital · NCT07350837CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053462Studies on Adsorption International Learning Initiative Global
NA · 1 location(s) · Botkin Hospital · NCT07123909BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06741072
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.